Charles Holley - Amgen Insider

Amgen Inc -- USA Stock  

USD 183.55  0.05  0.0272%


Mr. Charles M. Holley, Jr., serves as Director of the Company. Mr. Holley has served as a director of the Company since February 1, 2017. Mr. Holley was first identified to the Governance and Nominating Committee as a potential director candidate by the Companys outside search firm. Mr. Holley is the former Executive Vice President and Chief Financial Officer for WalMart Stores, Inc., or Walmart, where he served from November 2010 to December 2015 and as Executive Vice President between January 1, 2016 and January 31, 2016. Prior to this, Mr. Holley served as Executive Vice President, Finance and Treasurer of Walmart from 2007 to November 2010. From December 2005 through December 2006, he served as Senior Vice President. Prior to that, Mr. Holley was Senior Vice President and Controller from 2003 to 2005. Mr. Holley served various roles in WalMart International from 1994 through 2002. Prior to this, Mr. Holley served in various roles at Tandy Corporationrationration. He spent more than ten years with Ernst Young LLP. Mr. Holley is an Independent Senior Advisor, U.S. CFO Program, Deloitte LLP, a privatelyheld provider of audit, consulting, tax, and advisory services, since July 2016.
Age: 59  Director Since 2017      
Holley serves on the Dean Advisory Board for the McCombs School of Business at the University of Texas at Austin and the University of Texas Presidents' Development Board.

Management Efficiency

The company has return on total asset (ROA) of 8.32 % which means that it generated profit of $8.32 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 7.18 % meaning that it created $7.18 on every $100 dollars invested by stockholders.
The company currently holds 35.34 B in liabilities with Debt to Equity (D/E) ratio of 140.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 5.38 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives


David GreenwayVertex Pharmaceuticals Incorpor
Samuel ScottAbbott Laboratories
Arthur HigginsEndo International plc
Daniel StarksAbbott Laboratories
William SpenglerEndo International plc
Deborah NeffBio Rad Laboratories Inc
James FarrellAbbott Laboratories
Michael HyattEndo International plc
Yuchun LeeVertex Pharmaceuticals Incorpor
Sharad MansukaniEndo International plc
Alan GarberVertex Pharmaceuticals Incorpor
Jill SmithEndo International plc
Adriane BrownAllergan plc
Douglas IngramEndo International plc
Glenn TiltonAbbott Laboratories
Bruce SachsVertex Pharmaceuticals Incorpor
Joel McCombBio Rad Laboratories Inc
Fred WeissAllergan plc
Robert AlpernAbbott Laboratories
Robert MalchioneBio Rad Laboratories Inc
Phebe NovakovicAbbott Laboratories

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ exchange. It employs 20800 people.Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 20,800 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Wanda Austin, Director
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators